HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Rare pancreatic endocrine tumors].

Abstract
Functional pancreatic endocrine tumors other than gastrinoma and insulinoma are quite rare. Some of these tumors may be part of multiple endocrine neoplasia type one (MEN-1) syndrome or phakomatoses. Depending on their cell type, functional pancreatic endocrine tumors may cause distinct clinical endocrine syndromes, such as the 'glucagonoma syndrome', Verner-Morrison syndrome and the 'somatostatinoma syndrome'. The significant progress made in recent years, especially in the field of imaging procedures, has brought about great improvement in the identification and differentiation of these neoplasms. Currently, the only curative treatment for islet cell tumors is complete surgical resection. The medical treatment of endocrine pancreatic tumours consists of somatostatin analogues, chemotherapy, and interferon-alpha. The purpose of this manuscript is to provide an overview of the contemporary etiopathogenesis, diagnosis and treatment of rare pancreatic endocrine tumors.
AuthorsRobert Krysiak, Bogustław Okopień, Zbigniew Stanisław Herman
JournalPrzeglad lekarski (Przegl Lek) Vol. 65 Issue 4 Pg. 209-16 ( 2008) ISSN: 0033-2240 [Print] Poland
Vernacular TitleRzadkie guzy endokrynne trzustki.
PMID18724549 (Publication Type: English Abstract, Journal Article, Review)
Topics
  • Glucagonoma (diagnosis, therapy)
  • Humans
  • Pancreatic Neoplasms (diagnosis, therapy)
  • Rare Diseases (diagnosis, therapy)
  • Somatostatinoma (diagnosis, therapy)
  • Vipoma (diagnosis, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: